Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,407 across all filing types
Latest filing 2026-02-06 Major Shareholding Noti…
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-02-06 English
Update on Saphnelo subcutaneous administration
Regulatory Filings Classification · 98% confidence The document is an official regulatory announcement from AstraZeneca PLC distributed via the London Stock Exchange's RNS (Regulatory News Service). It provides a specific update regarding a US FDA regulatory review (a Complete Response Letter) for a drug application. While it contains detailed medical and clinical trial information, it is fundamentally a regulatory news announcement rather than a full financial report, investor presentation, or legal proceeding document. It fits the definition of a Regulatory Filing (RNS) as it is a standard corporate announcement disseminated through a primary information provider.
2026-02-03 English
6-K Filing
Regulatory Filings
2026-02-03 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a regulatory notification regarding the total number of voting rights and issued share capital, filed in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of disclosure is a standard regulatory requirement for listed companies to inform shareholders of the denominator for interest notification calculations. It does not represent a major shareholding notification (MRQ) by a specific investor, nor a share issue (SHA), but rather a periodic regulatory update on capital structure. Therefore, it falls under the general regulatory filing category.
2026-02-02 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is a regulatory notification from AstraZeneca PLC regarding 'Voting rights and capital' in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. It provides the total number of voting rights and issued share capital as of a specific date. This type of disclosure is a standard regulatory requirement for listed companies to inform shareholders of their denominator for transparency calculations. While it relates to share capital, it is specifically a regulatory disclosure of voting rights rather than a transaction in own shares or a new share issuance announcement, making 'RNS' (Regulatory Filings) the most appropriate category for this type of mandatory regulatory update.
2026-02-02 English
Imfinzi recommended in EU for early gastric cancer
Regulatory Filings Classification · 98% confidence The document is a press release from AstraZeneca announcing that the CHMP (Committee for Medicinal Products for Human Use) has recommended the approval of their drug 'Imfinzi' for a specific cancer treatment in the EU. This is a standard corporate announcement regarding regulatory progress and clinical trial results, which falls under the 'Regulatory Filings' (RNS) category as it is a general regulatory/corporate announcement that does not fit into more specific categories like financial reports or shareholder meeting materials.
2026-02-02 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.